Author:
Li Su,Zhang Dongsheng,Sun Jian,Li Zhinming,Deng Liting,Zou Benyan,Zhan Jing,Jiang Wenqi
Subject
Immunology,Immunology and Allergy
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Quantitation and Identification of Therapeutic Anti-CD22 Monoclonal Antibodies in a Cell-Based ELISA Method;Antibodies;2022-08-16
2. SM03, an Anti-CD22 Antibody, Converts Cis-to-Trans Ligand Binding of CD22 against α2,6-Linked Sialic Acid Glycans and Immunomodulates Systemic Autoimmune Diseases;The Journal of Immunology;2022-06-15
3. An open-label, multiple-dose study to assess the preliminary pharmacokinetics, pharmacodynamics, clinical activity, and safety of human mouse chimeric anti-CD22 monoclonal antibody (SM03) in patients with rheumatoid arthritis;Int. Journal of Clinical Pharmacology and Therapeutics;2021-11-01
4. SM03, an anti-human CD22 monoclonal antibody, for active rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled study;Rheumatology;2021-09-11
5. Recent clinical trials utilizing chimeric antigen receptor T cells therapies against solid tumors;Cancer Letters;2017-04